Add to ORKGEfficacy and Safety of Bendamustine and Rituximab As First Salvage Treatment in Chronic Lymphocytic Leukemia: Results of the Gimema-Eric LLC1315 Stud
We conducted a phase II, noncomparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie EM...
We conducted a phase II, non-comparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie E...
We conducted a phase II, noncomparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie EM...
We performed an observational study on the efficacy of bendamustine and rituximab (BR) as first salv...
We performed an observational study on the efficacy of ben-damustine and rituximab (BR) as first sal...
We performed an observational study on the efficacy of ben-damustine and rituximab (BR) as first sal...
MABLE investigated the efficacy and safety of rituximab plus bendamustine or rituximab plus chloramb...
Purpose We investigated the safety and efficacy of bendamustine and rituximab (BR) in previously unt...
Purpose The objective of this trial was to evaluate safety and efficacy of bendamustine combined wit...
Bendamustine was developed in East Germany as a potent alky-lating agent. Bendamustine monotherapy w...
By using the GRADE system we produced the following recommendations for the use of bendamustine in t...
By using the GRADE system we produced the following recommendations for the use of bendamustine in t...
Bendamustine proved to be effective for the treatment of chronic lymphocytic leukemia (CLL). However...
<p>Efficacy and safety results of rituximab and bendamustine combination (Scheme BR) in patients wit...
We conducted a phase II, noncomparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie EM...
We conducted a phase II, noncomparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie EM...
We conducted a phase II, non-comparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie E...
We conducted a phase II, noncomparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie EM...
We performed an observational study on the efficacy of bendamustine and rituximab (BR) as first salv...
We performed an observational study on the efficacy of ben-damustine and rituximab (BR) as first sal...
We performed an observational study on the efficacy of ben-damustine and rituximab (BR) as first sal...
MABLE investigated the efficacy and safety of rituximab plus bendamustine or rituximab plus chloramb...
Purpose We investigated the safety and efficacy of bendamustine and rituximab (BR) in previously unt...
Purpose The objective of this trial was to evaluate safety and efficacy of bendamustine combined wit...
Bendamustine was developed in East Germany as a potent alky-lating agent. Bendamustine monotherapy w...
By using the GRADE system we produced the following recommendations for the use of bendamustine in t...
By using the GRADE system we produced the following recommendations for the use of bendamustine in t...
Bendamustine proved to be effective for the treatment of chronic lymphocytic leukemia (CLL). However...
<p>Efficacy and safety results of rituximab and bendamustine combination (Scheme BR) in patients wit...
We conducted a phase II, noncomparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie EM...
We conducted a phase II, noncomparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie EM...
We conducted a phase II, non-comparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie E...
We conducted a phase II, noncomparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie EM...